70.85 USD
↗ 1.64 (2.37%)AT CLOSE (11:59 AM EDT)
Shares of PTC Therapeutics, Inc. (PTCT) are trading at $70.86. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, exceptional Return on Equity (23.2%) and a bullish Golden Cross on the moving averages. PTCT is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Aug 6, 2026.